City of Hope opens first U.S. multicenter clinical trial for robotic single-port mastectomies for breast cancer patients
LOS ANGELES — City of Hope, one of the largest cancer research and treatment organizations in the United States, is opening ...
Tag: trial
Advanced bladder cancer patients could keep their bladder under new treatment regime, clinical trial shows
New York, NY (October 2, 2023)—Mount Sinai investigators have developed a new approach for treating invasive bladder cancer without the ...
Women seeking credibility in health care feel ‘on trial,’ struggle with constraints of double binds
CHAMPAIGN, Ill. — Having a chronic illness is a great deal of work, communication researchers have long known. But having ...
Clinical trial to test immune modulation strategy for hospitalized COVID-19 patients begins
A clinical trial has launched to test whether early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness ...
Australian research leads to clinical trial for rare women’s cancers
An international clinical trial exploring a new way to treat rare and aggressive gynaecological cancers has launched in Melbourne. Credit: ...
University of Pittsburgh launches trial tackling leading cause of death in kids
The No. 1 cause of death in children is trauma. There are an estimated 2,000 pediatric deaths from traumatic bleeding ...
Clinical trial of HIV vaccine begins in United States and South Africa
WHAT: A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The ...
Dana-Farber leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma
EMBARGOED: September 18, 2023 4PM EST CONTACT: Nicole Oliverio, nicole_oliverio@dfci.harvard.edu, 617-257-0454 Boston – An innovative phase 2 clinical trial led ...
NIH clinical trial of universal flu vaccine candidate begins
Enrollment in a Phase 1 trial of a new investigational universal influenza vaccine candidate has begun at the National Institutes ...
UCI researchers announce publication of an open-label clinical trial suggesting that N-acetylglucosamine restores neurological function in Multiple Sclerosis patients
Irvine, CA – Sept. 14, 2023 – UCI researchers have found that a simple sugar, N-acetylglucosamine, reduces multiple inflammation and ...
Trial: Combination immunotherapy prior to lung cancer surgery appears promising
Patients with stage 1–3 non-small cell lung cancer (NSCLC) given a combination immunotherapy prior to surgery (neoadjuvant) had a better ...
$3.5 million NIH grant funds the first-ever clinical trial of ketone supplementation to treat and or prevent frailty
The Buck Institute for Research on Aging has received a $3.5 million federal grant to lead the first-ever double-blind, randomized, ...
MARS trial: decortication and chemotherapy associated with worse outcomes for patients with resectable mesothelioma
(Singapore, September 11, 2023, 10:05 a.m. SGT) – Extended pleurectomy decortication combined with chemotherapy is associated with worse survival outcomes, ...
KRYSTAL-1 trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations
— The oral, selective KRAS G12C inhibitor The oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity, ...
Lung-MAP master protocol model broadens trial access for some underrepresented groups
As compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cancer Master Protocol ...
Phase I clinical trial shows treatment designed to clear senescent cells in Alzheimer’s disease is safe
WINSTON-SALEM, N.C. – Sept. 7, 2023 – Alzheimer’s disease is the most common cause of dementia that affects more than ...
Johns Hopkins Medicine awarded $24.5 million grant for trial innovation center
Thanks to a $24.5 million grant from the National Institutes of Health National Center for Advancing Translational Sciences (NCATS), Johns ...
Embargoed – Potent oral agent that acts as both immunotherapy and targeted treatment produces high response rate in patients with hard-to-treat and refractory multiple myeloma when combined with steroid, trial shows
EMBARGOED: August 30, 2023, 5PM EST Contact: Nicole Oliverio, 617-257-0454, nicole_oliverio@dfci.harvard.edu Potent Oral Agent That Acts as Both Immunotherapy and ...
Trial re-evaluates routine defibrillator implantation after myocardial infarction
Amsterdam, Netherlands – 26 Aug 2023: Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial infarction survivors ...
Clinical trial studying possible new treatment option for patients with NAFLD
According to the National Institutes of Health, approximately 24% of adults in the United States have nonalcoholic fatty liver disease ...
-
Pumped for frigid weather: study pinpoints cold adaptations in nervous system of Antarctic octopus
-
Men with metastatic prostate cancer live longer thanks to new drugs
-
Researchers propose a unified, scalable framework to measure agricultural greenhouse gas emissions
-
Gut bacteria found in wild wolves may be key to improving domestic dogs’ health
-
Genomic analysis reveals ancient cancer lineages in clams
-
Study uncovers reasons Americans did not get booster vaccines